PELP1 is also recently identified as a proto-oncogene [15] that exhibits aberrant expression in many hormone-related cancers [16] and is a prognostic indicator of shorter breast cancer-specific survival and disease-free intervals when over-expressed [17]. The gene discussed is PELP1; the disease is breast carcinoma.